All MiMedx Group articles

  • /web/img/field/image/sec_0.jpg
    Article

    SEC charges MiMedx Group with accounting fraud

    2019-11-27T15:23:00Z

    Biotech company MiMedx Group and three of its former top executives have been charged with defrauding investors. In response, MiMedx reshuffled its management team, including the appointment of a new general counsel and secretary.

  • Blog post

    MiMedx makes leadership changes amid accounting probe

    2018-07-19T15:00:00Z

    MiMedx Group, a developer and marketer of regenerative and therapeutic biologics, has appointed Mark Graves as chief compliance officer. The company also is conducting a formal search to fill the newly established positions of chief accounting officer and internal auditor, amid an ongoing investigation into accounting violations.